Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma

BACKGROUND: SLFN11 has been found to regulate the development and progression of a variety of cancers and is associated with drug therapy, while its role in clear cell renal cell carcinoma (ccRCC) remains unclear; therefore, the aim of this study was to investigate SLFN11 expression in ccRCC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yifu, Zhang, Zhicheng, Fu, Shengqiang, Wang, Siyuan, Cheng, Xiaofeng, Lei, Kunyang, Li, Zhilong, Sun, Ting, Ma, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521339/
https://www.ncbi.nlm.nih.gov/pubmed/34675634
http://dx.doi.org/10.2147/IJGM.S336823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521339/
https://www.ncbi.nlm.nih.gov/pubmed/34675634
http://dx.doi.org/10.2147/IJGM.S336823

Ejemplares similares